EirGenix provides not just technology services but integral solutions that you can rely on.
Eirgenix develops high quality biologic products, advancing an extensive pipeline of candidates to improve the lives of patients.
EirGenix Completed Its NTD 5.03 Billion Private Placement on the Fifteenth of October
EirGenix at CPhI Worldwide 2021 in Milan, Italy
EirGenix Achieves The Fourth Milestone Of Its Trastuzumab Biosimilar Licensing Agreement
Hong Hai/Foxconn Founder Terry Guo Announces Investment To Accelerate EirGenix’s Global Expansion
Our facility is located in Taiwan, and offers the service to clients around the world.
